Clinical Trial Update: A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing SH-1028 tablets to gefitinib in locally advanced or metastatic non-small cell lung cancer is in progress, with status not spe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• SH-1028 (SH-1028)

Snippet

Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN